Okamura J, Monden M, Kuroda C, Sakurai M
Nihon Geka Gakkai Zasshi. 1983 Sep;84(9):918-22.
Transcatheter arterial chemo-embolization (chemo-embolization) for treatment of unresectable liver cell cancer has now been widely used. Histological appraisal of chemo-embolization had been reported by us and many of cancers thus treated fell into complete necrosis. The present report deals with histological examination on 14 resected specimen of hepatocellular cancer in order to clarify the prevention from intrahepatic spread and therefore to elucidate the justification of preoperative chemo-embolization. One year actuarial survival rate of chemo-embolization followed by hepatic resection was 83%, while that of hepatic resection was 46% and that of chemo-embolization was 59%. Capsular invasion was observed in 83% of cases, but complete necrosis of the capsular invasion was seen in 60% of cases. Eighty-three percent of small cancer, less than 5 cm in diameter, showed completed necrosis of the capsular invasion. This necrotizing effect is beneficial for prevention from the recurrence of the resected stump when local excision is underwent in high risk patients. But once the bulky tumor emboli embedded and grew extensively in the portal vein, they could not be erased .
经导管动脉化疗栓塞术(化疗栓塞术)现已广泛用于治疗无法切除的肝细胞癌。我们已报道过化疗栓塞术的组织学评估情况,经此治疗的许多癌症出现了完全坏死。本报告对14例肝细胞癌切除标本进行了组织学检查,以阐明防止肝内扩散的方法,从而阐明术前化疗栓塞术的合理性。化疗栓塞术联合肝切除术后的1年精算生存率为83%,而单纯肝切除的1年精算生存率为46%,单纯化疗栓塞术的1年精算生存率为59%。83%的病例观察到包膜侵犯,但60%的包膜侵犯病例出现完全坏死。直径小于5 cm的小癌中,83%的病例包膜侵犯出现完全坏死。这种坏死效应有利于高危患者进行局部切除时防止切除残端复发。但一旦大量肿瘤栓子在门静脉内嵌入并广泛生长,就无法清除。